Ascendis Pharma A/S (ASND)

ASND trades at $200.26, 11.3% above the near-term max pain of $180 expiring Sep 19, 2025 (8 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($115-$260), indicating stable market expectations. Key magnetic zone at 170 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ASND shows stable levels around 180.83, reflecting balanced market expectations. The 80% spread signals divergent expectations across timeframes. Most levels below 200.26 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.